ARCHIVES

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

January 5, 1979

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director

April 22, 1994

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007